Dexmedetomidine is increasingly used to treat major withdrawal symptoms and hyperadrenergic
crisis. We present 3 young adult cases of cannabis/drug-induced delirium unresponsive
to traditional tranquilizer treatment but were responsive to dexmedetomidine as adjunct
therapy. All cannabis metabolite urine concentrations were greater than 264 ng/mL
upon presentation. Appropriate sedation was achieved within 5 hours in all 3 cases.
Thus, dexmedetomidine, along with other tranquilizers, was effective in treating delirium
due to cannabis/drug ingestion.
To read this article in full you will need to make a payment
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal.Ann Pharmacother. 2008; 42: 1703-1705
- Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU.Ann Intensive Care. 2012; 2: 1-6
- Dexmedetomidine: an updated review.Ann Pharmacother. 2007; 41: 245-254
- Prevalence of delirium and coma in mechanically ventilated patients sedated with dexmedetomidine or propofol.Pharm Ther. 2016; 41: 442-445
- Double-blind randomized controlled trial of intranasal dexmedetomidine versus intranasal midazolam as anxiolysis prior to pediatric laceration repair in the emergency department.Acad Emerg Med. 2016; 23: 910-917
- Delirium (acute confusional states).JAMA. 1987; 258: 1789-1792
- A clinical update on delirium: from early recognition to effective management.Nurs Res Pract. 2011; 2011 ([12 pages])875196https://doi.org/10.1155/2011/875196
- Delirium following ingestion of marijuana present in chocolate cookies.CNS Spectr. 2006; 11: 262-264
- Case report: adverse effects of taking tricyclic antidepressants and smoking marijuana.Can Fam Phys. 1999; 45: 2683-2684
- Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants.J Am Acad Child Adolesc Psychiatry. 1997; 36: 45-48
- Concurrent and sustained cumulative effects of adolescent marijuana use on subclinical psychiatric symptoms.Am J Psychiatry. 2016; 173: 781-789
- A cannabinoid-intoxicated child treated with dexmedetomidine: a case report.J Med Case Reports. 2015; 9: 152https://doi.org/10.1186/s13256-015-0636-2
- Central sympathology as a novel counter measure for cocaine-induced sympathetic activation and vasoconstriction in humans.J Am Coll Cardiol. 2007; 50: 626-633
- Dexmedetomidine to treat lisdexamfetamine overdose and serotonin toxicidrome in a 6-year-old girl.Am J Crit Care. 2012; 21: 456-459
- Use of dexmedetomidine in the treatment of scorpion envenomation.Clin Toxicol. 2009; 47: 763
- Evaluation of dexmedetomidine therapy for sedation in patients with toxicological events at an academic medical center.Clin Toxicol. 2014; 52: 525-530
- Dexmedetomidine as an adjunct in patients undergoing treatment for ethanol withdrawal in the critical care setting.Clin Toxicol. 2015; 50: 579-580
Article Info
Publication History
Published online: October 10, 2016
Accepted:
October 9,
2016
Received in revised form:
October 7,
2016
Received:
September 30,
2016
Footnotes
☆Presented at the North American Congress of Clinical Toxicology Boston, MA; September 2016
Identification
Copyright
© 2016 Elsevier Inc. All rights reserved.
